"THE USE OF SU 4885 (METHOPYRAPONE) TO STUDY THE PITUITARY ACTH RESERVE IN PATIENTS WITH SHEEHAN'S DISEASE AND PITUITARY TUMORS".
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000324:Adrenocorticotropic Hormone; D035843:Biomedical Research; D019411:Clinical Laboratory Techniques; D007018:Hypopituitarism; D008797:Metyrapone; D000451:Mineralocorticoid Receptor Antagonists; D010902:Pituitary Gland; D010911:Pituitary Neoplasms; D014556:Urine
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000451:Mineralocorticoid Receptor Antagonists; D000324:Adrenocorticotropic Hormone; D008797:Metyrapone
17-HYDROXYCORTICOSTEROIDS; 17-KETOSTEROIDS; ALDOSTERONE ANTAGONISTS; CLINICAL RESEARCH; CORTICOTROPIN; DIAGNOSIS, LABORATORY; HYPOPITUITARISM; METYRAPONE; PITUITARY NEOPLASMS; SHEEHAN'S SYNDROME; URINE